Lamis
Lv11
70 积分
2024-06-11 加入
-
Physical exercise and fatigue in advanced gastrointestinal cancer during chemotherapy
10天前
已完结
-
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature
3个月前
已完结
-
Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer
3个月前
已完结
-
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial
4个月前
已完结
-
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
4个月前
已完结
-
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial
4个月前
已完结